Kimidaru Company (DKIMI) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DKIMI
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/09/30 | To 1401/09/30 | To 1400/09/30 |
|---|---|---|---|---|---|---|
| Operating revenue | 15,856,912 | 7,034,369 | 5,257,259 | 7,709,736 | 6,924,641 | 3,469,133 |
| Cost of operating revenue | -7,763,760 | -4,890,979 | -4,170,166 | -5,437,982 | -4,015,444 | -2,208,109 |
| Gross profit (loss) | 8,093,152 | 2,143,390 | 1,087,093 | 2,271,754 | 2,909,197 | 1,261,024 |
| Selling, general and administrative expenses | -1,014,256 | -683,036 | -502,307 | -358,701 | -348,170 | -221,094 |
| Other income | 3,600 | 9,052 | 19,654 | 13,965 | 8,738 | 10,277 |
| Other expenses | -1,030,854 | -67,706 | -11,667 | -49,939 | -32,797 | -6,475 |
| Operating profit (loss) | 6,051,642 | 1,401,700 | 592,773 | 1,877,079 | 2,536,968 | 1,043,732 |
| Finance costs | -1,203,918 | -877,787 | -1,125,000 | -1,030,625 | -520,507 | -477,703 |
| Other non-operating income and expenses | 1,182 | -85,776 | 70,007 | 549,319 | 683,902 | 120,501 |
| Profit (loss) from continuing operations before tax | 4,848,906 | 438,137 | -462,220 | 1,395,773 | 2,700,363 | 686,530 |
| Current year tax | -969,781 | -65,721 | 0 | -157,574 | -499,418 | -113,351 |
| Net profit (loss) from continuing operations | 3,879,125 | 372,416 | -462,220 | 1,238,199 | 2,200,945 | 573,179 |
| Net profit (loss) | 3,879,125 | 373,063 | -462,220 | 1,238,199 | 2,200,945 | 573,179 |
| Basic earnings (loss) per share | 8,179 rials | 647 rials | 802 rials | 2,149 rials | 0 rials | 0 rials |
| Net earnings (loss) per share, rials | 6,735 rials | 648 rials | -802 rials | 2,150 rials | 3,822 rials | 996 rials |
| Capital | 576,000 | 576,000 | 576,000 | 576,000 | 576,000 | 576,000 |
Reporting periods
96 periods are on file for this report, from the period ending 1380/09/30 to the period ending 1405/06/31.